[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fjscrebsY8MzjE9K1Vf3AUCN26fXwq2rjWzO6muoEEJw":8,"$fDyksc8jFivgDlQyp5pDZDiZmslvFsEO4SrXkRC852dA":55,"$fvdVhDbI_hr_SKdyS-FP0vjMvhZuitV5x_ckLtbTJRXo":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},54197,867218,[],"https://ystcdn.venuertc.com/medical/ystApp/PNv1JgZKMO3NbzWop7HvWPziztZOf4zJ.png","吕昭宝","聊城市第二人民医院","甲状腺乳腺外科","主治医师",183,0,"乳腺癌早期化疗用药实用指南：多柔比星脂质体与环磷酰胺全解","","https://ystcdn.venuertc.com/venue/AI/5d72bf98-c2f4-4da8-b620-821de61f3b35.jpg","\u003Cdiv class=\"pharmacist-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"pharmacist-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    乳腺癌早期化疗用药实用指南：多柔比星脂质体与环磷酰胺全解\n  \u003C/h1>\n\n  \u003Cdiv class=\"pharmacist-intro pharmacist-bg1\">\n    \u003Cp>\n      聊到化疗用药，\u003Cb>多柔比星脂质体\u003C/b>和\u003Cb>环磷酰胺\u003C/b>是肿瘤治疗领域广泛应用的基础成员。它们属于细胞毒类药物，被用于多种肿瘤的规范治疗方案内。用药时，细节决定疗效和安全。本文将用\u003Cb>7个关键细节\u003C/b>，带你全面掌握这两类药品的正确使用方法和风险防范要点。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 剂型选择与服用技巧 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型与给药方式，了解前提很重要\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>多柔比星脂质体为\u003Cstrong>静脉注射剂\u003C/strong>，是将活性药物包裹于特殊脂质体内，提高靶向性，并降低心脏毒性 \u003Cspan class=\"pharmacist-emoji\">💉\u003C/span>。\u003C/li>\n        \u003Cli>环磷酰胺也主要以\u003Cstrong>静脉注射剂\u003C/strong>使用，部分情况下可用口服剂型。\u003C/li>\n        \u003Cli>正确做法：\u003Cb>必须由专业医生在医院静脉输注\u003C/b>，严禁自行注射或自行调整剂量。\u003C/li>\n        \u003Cli>静脉用药期间需要严密监测，药物不得经口服、肌注或其他途径自行更换。\u003C/li>\n        \u003Cli>输注时应使用透明输液管，避免药物泄漏，防止皮下渗漏导致局部损伤。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pharmacist-tip\">案例：一位65岁女性患者在医院规范静脉使用多柔比星脂质体联合环磷酰胺后，未出现局部不良反应，说明专业操作的重要性。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药物成分与作用机制 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 成分与机制：核心原理要清楚\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>多柔比星脂质体\u003C/b>成分为蒽环类抗生素，通过干扰DNA合成，阻止细胞繁殖。\u003C/li>\n        \u003Cli>\u003Cb>环磷酰胺\u003C/b>为烷化剂，进入体内后转化为活性代谢产物，同样以破坏DNA为主要机制。\u003C/li>\n        \u003Cli>脂质体包裹设计，目的在于减少传统多柔比星对心脏及其他组织的损伤。\u003C/li>\n        \u003Cli>两药常组合使用，协同增强细胞损伤效应。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pharmacist-ref\">\n        引用：Gabizon, A., et al. \"Doxorubicin HCl liposome injection: a review of pharmacodynamic and pharmacokinetic properties and clinical data.\" \u003Cem>Drugs\u003C/em> (2003); Emadi, A., Jones, R. & Brodsky, R. \"Cyclophosphamide and cancer: golden anniversary.\" \u003Cem>Nature Rev. Clin. Oncol.\u003C/em> (2009).\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 用药时间安排与周期 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg4\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用药时间与周期：遵循方案不可随意\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>标准化疗方案由医生根据体重、体表面积、肝肾功能等\u003Cstrong>个体参数专属设计\u003C/strong>。\u003C/li>\n        \u003Cli>多柔比星脂质体和环磷酰胺多按\u003Cstrong>间歇性给药方案\u003C/strong>，常为每隔3周为一周期。\u003C/li>\n        \u003Cli>每个周期通常含输注和间歇期，确保身体有时间恢复。\u003C/li>\n        \u003Cli>正确做法：严格按医嘱定期到院输注，不自行提前、推迟或漏用任何一次。\u003C/li>\n        \u003Cli>化疗期间需按期复查血常规、肝肾功能以决定是否适合继续下次用药。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pharmacist-emoji\">⏰\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 服药前预处理与联合用药 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg5\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 预处理与联合用药方案\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>化疗前通常需给予\u003Cstrong>止吐药\u003C/strong>（如5-HT3受体拮抗剂）预处理，以减少恶心呕吐风险。\u003C/li>\n        \u003Cli>部分方案可合用生理盐水、地塞米松等辅助药物，提高安全体验。\u003C/li>\n        \u003Cli>不得自行添加、停用任何辅助药品，所有组合用药需遵从医嘱。\u003C/li>\n        \u003Cli>注意：如有药物过敏史，务必提前告知医护人员。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pharmacist-tip\">案例：临床上常见患者遵医嘱多药联合用药后恶心症状减轻，提高了化疗的依从性。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 主要副作用与处理对策 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg6\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 不良反应与管理办法如何应对\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>多柔比星脂质体的主要副作用为\u003Cstrong>骨髓抑制\u003C/strong>（表现为血细胞减少），偶有心脏毒性。\u003C/li>\n        \u003Cli>环磷酰胺同样可能导致骨髓抑制、脱发和泌尿系统副反应。\u003C/li>\n        \u003Cli>部分人可出现皮肤色素沉着、消化道轻微不适。\u003C/li>\n        \u003Cli>出现发热、咽痛、异常出血、尿液特殊气味、明显乏力时，务必及时与主治医生联系。\u003C/li>\n        \u003Cli>症状轻微时根据医嘱可调整支持措施或延后下次用药；严重时或怀疑过敏反应应立即就医。\u003C/li>\n        \u003Cli>一项临床数据表明，多柔比星脂质体心脏毒性显著低于传统蒽环类（Gabizon et al., 2003）。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"pharmacist-emoji\">🚦\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 药物相互作用警示 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg7\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 避免药物相互作用：谨防组合风险\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>多柔比星脂质体禁与其它蒽环类药品同用，以规避剂量累计毒性。\u003C/li>\n        \u003Cli>与环磷酰胺合用时需做好骨髓抑制监控。\u003C/li>\n        \u003Cli>同时服用抗癫痫药、苯巴比妥等可影响药效，需医生调整剂量。\u003C/li>\n        \u003Cli>避免同时用保肝类药物（如酮康唑等强抑制剂）以免加重肝脏负担。\u003C/li>\n        \u003Cli>如正在服用其他药物（包括中成药、保健品），务必提前主动申报予医生。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pharmacist-ref\">\n        引用：Robert, J., & Gianni, L. \"Pharmacokinetics and toxicities of doxorubicin in patients.\" \u003Cem>Semin. Oncol.\u003C/em> (1990).\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 适应症与禁忌症分明 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg8\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 适应症与禁忌症，不能混淆\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>两药严格根据医生诊断结果决定是否使用，患者\u003Cstrong>不可自行购买或更换方案\u003C/strong>。\u003C/li>\n        \u003Cli>凡对多柔比星、环磷酰胺或辅料有明确过敏史者，\u003Cb>绝对禁用\u003C/b>。\u003C/li>\n        \u003Cli>近期有严重心脏病、严重肝肾功能不全需谨慎，可能需要调整方案或延后用药。\u003C/li>\n        \u003Cli>用药期间怀孕、哺乳、未成年患者应单独咨询专业医师。\u003C/li>\n        \u003Cli>如同时患有其他慢性病，主动提供完整药物使用史便于医师整体判断。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"pharmacist-emoji\">❗\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存方法及注意事项 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg9\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存要求与有效期，细节不可忽视\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>多柔比星脂质体原液应存放于2～8°C阴凉、避光环境下，不应冷冻。\u003C/li>\n        \u003Cli>环磷酰胺注射液同样需低温冷藏保存，避免阳光直射、温度过高。\u003C/li>\n        \u003Cli>配好溶液后一般当天使用，剩余部分须按照医疗废物处理，不可带回家再次使用。\u003C/li>\n        \u003Cli>过期、变色、出现沉淀的药液必须废弃，不可使用。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pharmacist-tip\">操作习惯决定安全：每次存取药液、输液过程须查验批号与有效期，严格核对。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏用与过量如何处理 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg10\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏用与过量的应对措施\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>化疗药需要在医院专人操作，几乎不会出现漏服问题；如有不适应及时沟通，由医护人员判断是否可延后或补用。\u003C/li>\n        \u003Cli>过量使用多柔比星脂质体与环磷酰胺会加重骨髓抑制及脏器损伤，必须立即就医。\u003C/li>\n        \u003Cli>出现呼吸急促、严重出血、昏迷等体征，应立刻前往急诊处理。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 总结/再强调 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg11\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 小结：把握关键，用药更安心\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content\">\n      \u003Cul>\n        \u003Cli>多柔比星脂质体和环磷酰胺作为常用化疗药，正确用药、科学监测和严防风险是成功治疗和副作用防控的基石。\u003C/li>\n        \u003Cli>牢牢记住：\u003Cb>只在医院专业条件下使用\u003C/b>，不可随意调整每次输注的方案、周期和剂量。\u003C/li>\n        \u003Cli>出现不适立即与医生联系，严格遵守各项安全操作规范，同时关注药物储存。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"pharmacist-emoji\">🔑🩺\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"pharmacist-section\">\n    \u003Ch2 class=\"pharmacist-subtitle pharmacist-bg12\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cdiv class=\"pharmacist-content pharmacist-ref\">\n      \u003Cul>\n        \u003Cli>\n          Gabizon, A., et al. (2003). Doxorubicin HCl liposome injection: a review of pharmacodynamic and pharmacokinetic properties and clinical data. \u003Cem>Drugs\u003C/em>, 63(10), 1029-1050.\n        \u003C/li>\n        \u003Cli>\n          Emadi, A., Jones, R. J., & Brodsky, R. A. (2009). Cyclophosphamide and cancer: golden anniversary. \u003Cem>Nature Reviews Clinical Oncology\u003C/em>, 6(11), 638-647.\n        \u003C/li>\n        \u003Cli>\n          Robert, J., & Gianni, L. (1990). Pharmacokinetics and toxicities of doxorubicin in patients. \u003Cem>Seminars in Oncology\u003C/em>, 17(2 Suppl 3), 14-19.\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.pharmacist-guide-container {\n  background: #fafbfc;\n  font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  color: #223344;\n  max-width: 830px;\n  margin: 38px auto;\n  border-radius: 18px;\n  box-shadow: 0 4px 28px 0 rgba(124, 195, 231, 0.10);\n  padding: 46px 36px 48px 36px;\n}\n\n.pharmacist-title {\n  font-size: 2.2em;\n  font-weight: 700;\n  text-align: center;\n  margin-bottom: 32px;\n  border-bottom: 2px solid #c6e2f7;\n  letter-spacing: 1.5px;\n  padding-bottom: 8px;\n  color: #174379;\n  background: linear-gradient(90deg, #e6f0fa 50%, #fafdff 100%);\n  border-radius: 18px;\n}\n\n.pharmacist-intro {\n  font-size: 1.23em;\n  padding: 25px 28px;\n  margin-bottom: 34px;\n  border-left: 7px solid #40a9ff;\n  border-radius: 10px;\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n\n.pharmacist-section {\n  margin-bottom: 34px;\n  padding: 0 2px;\n}\n\n.pharmacist-subtitle {\n  font-size: 1.32em;\n  font-weight: 600;\n  margin-bottom: 17px;\n  padding: 12px 16px;\n  border-radius: 9px;\n  color: #256ec2;\n  letter-spacing: .9px;\n  background-repeat: no-repeat;\n  background-size: cover;\n  background-position: 15% 50%;\n  text-shadow: 0 1px 8px #fff9;\n  border-left: 6px solid #3b90e9;\n}\n\n.pharmacist-content {\n  font-size: 1.05em;\n  padding: 18px 16px 6px 24px;\n  background: #f6fbff;\n  border-radius: 8px;\n  box-shadow: 0 2px 6px 0 rgba(124, 195, 231, 0.08);\n}\n\n.pharmacist-content ul {\n  margin: 0 0 2px 0;\n  padding: 0;\n  list-style: disc inside;\n}\n.pharmacist-content li {\n  margin-bottom: 8px;\n  line-height: 1.8em;\n}\n\n.pharmacist-emoji {\n  font-size: 1.22em;\n  vertical-align: middle;\n  margin-left: 3px;\n}\n\n.pharmacist-tip {\n  background: #e8f6fb;\n  border-left: 4.5px solid #46b7e9;\n  color: #1595aa;\n  margin: 18px 0 10px 0;\n  padding: 7px 17px 7px 17px;\n  border-radius: 8px;\n  font-size: 1em;\n}\n\n.pharmacist-ref {\n  margin-top: 12px;\n  font-size: 0.98em;\n  color: #7a879b;\n  background: #f2f2f2;\n  border-left: 4px solid #4fa4e6;\n  border-radius: 7px;\n  padding: 8px 16px 8px 14px;\n}\n\n.pharmacist-bg1 { background: linear-gradient(110deg, #e7effd 55%, #fafdff 100%);}\n.pharmacist-bg2 { background: linear-gradient(103deg, #e4effb 35%, #f7faff 100%);}\n.pharmacist-bg3 { background: linear-gradient(95deg, #e3eefb 37%, #fafdff 100%);}\n.pharmacist-bg4 { background: linear-gradient(101deg, #e7f3fc 44%, #fcfcfe 100%);}\n.pharmacist-bg5 { background: linear-gradient(102deg, #e1f3f5 42%, #fbfdfe 100%);}\n.pharmacist-bg6 { background: linear-gradient(104deg, #eaf6f7 46%, #fcfefe 100%);}\n.pharmacist-bg7 { background: linear-gradient(99deg, #e5f2fe 35%, #fafdff 100%);}\n.pharmacist-bg8 { background: linear-gradient(101deg, #ecf3fb 48%, #fafdff 100%);}\n.pharmacist-bg9 { background: linear-gradient(90deg, #e6f0fa 50%, #fafdff 100%);}\n.pharmacist-bg10 { background: linear-gradient(100deg, #f2f8ff 43%, #fafdff 100%);}\n.pharmacist-bg11 { background: linear-gradient(95deg, #e1eef8 55%, #fafdff 100%);}\n.pharmacist-bg12 { background: linear-gradient(98deg, #e5effb 37%, #fafdff 100%);}\n\u003C/style>\n","\u003Cdiv class=\"pharmacist-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"pharmacist-title\" style=\"c",515,"2025-07-30 10:56:10","乳腺癌, 多柔比星脂质体, 环磷酰胺, 化疗药物, 副作用, 用药安全, 医疗指南","全面解析乳腺癌早期化疗中多柔比星脂质体与环磷酰胺的使用方法、安全要点和不良反应，帮助患者规范用药，提升治疗效果。","2025-07-30 16:52:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]